Chinese companies are accelerating the development of AI-powered BCIs, moving beyond laboratory trials toward practical real-world applications. Firms in China are combining neural implants with advanced AI algorithms to help people with paralysis regain abilities such as walking, speaking, and controlling digital devices. Start-ups and research groups are increasingly competing with Western companies such as Neuralink, while benefiting from strong state support, expanding clinical testing, and growing investment in neurotechnology infrastructure.
China’s approach focuses not only on the implant hardware itself, but on AI systems capable of decoding and interpreting brain signals more efficiently. Researchers believe this integration could accelerate rehabilitation technologies and improve communication tools for patients with neurological disorders. However, the rapid expansion of the sector also raises concerns regarding safety, regulation, transparency, and long-term ethical oversight, especially as these systems transition from experimental environments into broader medical and commercial use.
More information:
